Genemark
Douala
About Genemark
GENEMARK processes generic drugs (anti-infectious, anti-parasitic, anti-inflammatory …) and aims at the largest distribution scale thanks to an offer 30% to 50% cheaper than classical drugs. Genemark developers favor the production of liquid drugs (15 references over 27) in order to reduce overdose risks, particularly high in paludism treatments for children.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Jan 2008)
- Website: genemarkphar.fr
Industries & Categories
Health Care, Pharmaceutical, Wellness
Canonical: https://fsome.com/organization/genemark-1539220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.